Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Cara Therapeutics, Inc.    CARA

CARA THERAPEUTICS, INC.

(CARA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CARA THERAPEUTICS, INC.
02/25CARA : 4Q Earnings Snapshot
AQ
02/25CARA THERAPEUTICS  : Earnings Flash (CARA) CARA THERAPEUTICS Reports Q4 Revenue ..
MT
02/25CARA THERAPEUTICS  : Reports Fourth Quarter and Full Year 2020 Financial Results
AQ
02/18Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Res..
GL
01/12CARA THERAPEUTICS  : Initiates Phase 2 Trial of Oral KORSUVA for the Treatment o..
AQ
01/11CARA THERAPEUTICS  : Begins Phase II Study of Difelikefalin for Treatment of Pru..
MT
01/11Cara Initiates Phase 2 Trial of Oral KORSUVA™ for the Treatment of Prur..
GL
01/06CARA THERAPEUTICS  : to Present at the 39th Annual J.P. Morgan Healthcare Confer..
AQ
2020CARA THERAPEUTICS  : Submits New Drug Application to U.S. Food and Drug Administ..
AQ
2020CARA THERAPEUTICS  : Submits New Drug Application for Korsuva Injection
MT
2020Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administ..
GL
2020SWK  : ' Subsidiary, Enteris BioPharma, Receives $2.5Million Milestone Payment f..
MT
2020CARA THERAPEUTICS  : SWK Holdings' Subsidiary, Enteris BioPharma, Receives Secon..
PR
2020INSIDER TRENDS : Insider Prolongs 90-Day Selling Trend at Cara Therapeutics
MT
2020CARA THERAPEUTICS  : Completes Full Enrollment in KARE Phase 2 Trial of Oral KOR..
AQ
2020CARA THERAPEUTICS  : Completes Enrollment in Phase 2 Trial of Potential Dermatit..
MT
2020Cara Therapeutics Completes Full Enrollment in KARE Phase 2 Trial of Oral KOR..
GL
2020INSIDER TRENDS : Insider Sales Continue 90-Day Trend at Cara Therapeutics
MT
2020CARA THERAPEUTICS  : to Present at Multiple Upcoming Investor Conferences
AQ
2020Cara Therapeutics to Present at Multiple Upcoming Investor Conferences
GL
2020CARA : 3Q Earnings Snapshot
AQ
2020CARA THERAPEUTICS  : Earnings Flash (CARA) CARA THERAPEUTICS Posts Q3 Revenue $9..
MT
2020CARA THERAPEUTICS  : Reports Third Quarter 2020 Financial Results
AQ
2020Cara Therapeutics Reports Third Quarter 2020 Financial Results
GL
2020CARA THERAPEUTICS  : to Announce Third Quarter 2020 Financial Results on Novembe..
AQ
2020Cara Therapeutics to Announce Third Quarter 2020 Financial Results on Novembe..
GL
2020CARA THERAPEUTICS  : SWK Holdings' Subsidiary, Enteris BioPharma, Receives Miles..
PR
2020CARA THERAPEUTICS  : Announces Presentation at American Society of Nephrology Ki..
AQ
2020CARA THERAPEUTICS  : Announces Presentation at American Society of Nephrology Ki..
AQ
2020Cara Therapeutics Announces Presentation at American Society of Nephrology Ki..
GL
2020CARA THERAPEUTICS  : Vifor pharma and cara therapeutics sign us license agreemen..
AQ
2020Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva t..
AQ
2020CARA THERAPEUTICS  : and Vifor Pharma License Agreement Presentation
PU
2020CARA THERAPEUTICS  : Vifor Pharma and Cara Therapeutics sign US license agreemen..
AQ
2020Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva&..
GL
2020TITAN PHARMACEUTICALS  : Provides a Strategic and Corporate Update
AQ
2020CARA THERAPEUTICS  : Appoints Thomas Reilly as Chief Financial Officer
AQ
2020CARA THERAPEUTICS  : Appoints Thomas Reilly as Chief Financial Officer
AQ
2020Cara Therapeutics Appoints Thomas Reilly as Chief Financial Officer
GL
2020CARA : 2Q Earnings Snapshot
AQ
2020Cara Therapeutics Reports Second Quarter 2020 Financial Results
GL
2020Cara Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conf..
GL
2020Cara Therapeutics to Announce Second Quarter 2020 Financial Results on August..
GL
2020Cara Therapeutics Expands Board of Directors with Appointment of Susan Shiff,..
GL
2020CARA THERAPEUTICS  : Announces Completion of Interim Statistical Assessment for ..
AQ
2020Cara Therapeutics Announces Completion of Interim Statistical Assessment for ..
GL
2020CARA THERAPEUTICS  : 4
PU
2020Cara Therapeutics to Present at the Jefferies Virtual Healthcare Conference
GL
2020CARA : 1Q Earnings Snapshot
AQ
2020Cara Therapeutics Reports First Quarter 2020 Financial Results
GL
2020Cara Therapeutics to Present at the Virtual BofA Securities 2020 Health Care ..
GL
2020Cara Therapeutics to Announce First Quarter 2020 Financial Results on May 11,..
GL
2020CARA THERAPEUTICS  : VFMCRP and Cara Therapeutics announce positive results from..
AQ
2020Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Posi..
AQ
2020CARA THERAPEUTICS  : VFMCRP and Cara Therapeutics announce positive results from..
BU
2020Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Posi..
GL
2020Cara Therapeutics to Present at the Virtual 19th Annual Needham Healthcare Co..
GL
2020Cara Therapeutics Reports Clinical Updates
GL
2020CARA : 4Q Earnings Snapshot
AQ
2020Cara Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
GL
2020Cara Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Res..
GL
2020CARA THERAPEUTICS  : to Present at the 38th Annual J.P. Morgan Healthcare Confer..
AQ
2019SWK  : Enteris BioPharma's Licensing Partner, Cara Therapeutics, Announces Top L..
AQ
2019CARA THERAPEUTICS  : Announces Equity Grants to Employees under Inducement Plan
AQ
2019Cara Therapeutics Announces Equity Grants to Employees Under Inducement Plan
GL
2019CARA THERAPEUTICS  : Announces Positive Topline Data from Phase 2 Trial of Oral ..
AQ
2019Cara Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conf..
GL
2019Cara Therapeutics Announces Positive Topline Data From Phase 2 Trial of Oral ..
GL
2019Cara Therapeutics to Present at November Investor Conferences
GL
2019Cara Therapeutics Announces Publication of Difelikefalin (KORSUVA™ Inje..
GL
2019Cara Therapeutics Reports Third Quarter 2019 Financial Results
GL
2019Cara Therapeutics Announces Presentations at Kidney Week 2019
GL
2019Cara Therapeutics to Announce Third Quarter 2019 Financial Results on Novembe..
GL
2019Cara Therapeutics Announces Completion of Interim Statistical Assessment and ..
GL
2019CARA THERAPEUTICS  : Enteris BioPharma and Cara Therapeutics Enter into Licensin..
PR
1  2  3  4Next
Upcoming event on CARA THERAPEUTICS, INC.
05/06/21